Quartet of COVID-19 Vaccine Candidates Head Toward the Homestretch
William A. Haseltine, PhD
Viewed as a horse race, none of the four COVID-19 vaccine candidates whose developers released early clinical data this month fully broke away from the pack galloping toward regulatory approval.
However, a...
Inhaled Treatment Reduces Severe Covid-19 Risk by 79%
An experimental Covid-19 treatment that is delivered directly to the lungs via a nebulizer reduced the risk of mortality and the need for mechanical ventilation in a phase II trial.
In the trial, the lead...
Food Biotechnology Market Shaping from Growth to Value | Carbios, Monsanto, AquaBounty Technologies –...
COVID-19 Outbreak-Global Food Biotechnology study will help you investigate a detailed division of the market by the end user/industry, by best in class product type and by geography with creation, income, utilization, export &...
BTIG to Host Virtual Biotechnology Conference on August 10-11, 2020 – Business Wire
NEW YORK--(BUSINESS WIRE)--BTIG announced today that the “BTIG Virtual Biotechnology Conference” will take place on Monday, August 10th through Tuesday, August 11, 2020. The conference will be hosted by BTIG Biotechnology Analysts Dae Gon...
Junk DNA might be really, really useful for biocomputing
Flipon-based Computers
Credit: Alan Herbert
Dr. Herbert asks what if our genome was far smarter than everyone previously believed? What if in the many DNA repeat elements lay the foundation for building a novel type of...
Case Western Reserve University scientist receives DoD grant to develop freeze-dried artificial platelets
A Case Western Reserve University scientist, who has for more than a decade pioneered research into synthetic platelet substitutes, has been awarded a $3.8 million grant by the U.S. Department of Defense (DOD) to...
Translational Microbiomics Offsets Ecological Disruptions
Bioprocessing 4.0 emerges from a largely computation-based foundation, or at least it should. Nonetheless, lots of work remains to be done, and not necessarily in the places that even experts expect.
In writing about the...
Global €870M Fund Launched to Address Antimicrobial Resistance
A global collaboration including the pharmaceutical industry and public funders such as the European Investment Bank has committed to investing €870M ($1B) in tackling the growing crisis of antibiotic-resistant superbugs.
So far, over 20 pharmaceutical...
$65m investment increases British Patient Capital’s exposure to life sciences and health technology
Jul 21 2020
British Patient Capital announces a cornerstone commitment of $65m to SV Health Investors’ latest fund, SV7 Impact Medicine Fund (IMF), to turn scientific breakthroughs into biotech companies producing high impact precision medicine...
Staten Biotechnology, in collaboration with Novo Nordisk, starts dosing of anti-apoC3 antibody SST-5058 in...
NIJMEGEN, The Netherlands--(BUSINESS WIRE)--Staten Biotechnology B.V. announced today the initiation of dosing of the Company’s lead asset, STT-5058, in a First-in-Human clinical study.
STT-5058 is a monoclonal antibody that targets the lipoprotein ApoC3 and...
